Picture of Gerresheimer AG logo

GXI — Gerresheimer AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Gerresheimer AG - Reschedules Publication Of 2025 Financial Statements And Initiates Sale Of Centor Inc

Feb 10 (Reuters) - Gerresheimer AG GXIG.DE:

EQS-ADHOC: GERRESHEIMER AG RESCHEDULES PUBLICATION OF ANNUAL AND CONSOLIDATED FINANCIAL STATEMENTS FOR 2025 AND INITIATES SALE OF CENTOR INC.

GERRESHEIMER AG - RESCHEDULES PUBLICATION OF 2025 FINANCIAL STATEMENTS AND INITIATES SALE OF CENTOR INC

GERRESHEIMER AG - SEPARATION OF MOULDED GLASS BUSINESS ALSO BEING FURTHER PURSUED, BUT INTENDED SUBSEQUENT SALE PROCESS WILL NOT BE INITIATED IN 2026

GERRESHEIMER AG: EXPECTS NON-CASH IMPAIRMENTS OF AROUND EUR 220 TO 240 MILLION IN ITS CONSOLIDATED FINANCIAL STATEMENTS FOR FY 2025

GERRESHEIMER AG - FOR 2026 FINANCIAL YEAR, EXPECTS, BEFORE M&A ACTIVITIES, REVENUES OF AROUND EUR 2.3 TO 2.4 BILLION

GERRESHEIMER AG: DECREASE IN REVENUES IN 2025 EXPECTED TO BE AT UPPER END OF FORECAST RANGE OF -4% TO -2% OR SLIGHTLY BETTER

GERRESHEIMER AG - FOR  2026 FY EXPECTS AN ADJUSTED EBITDA MARGIN OF AROUND 18 TO 19%,

GERRESHEIMER AG: ADJUSTED EBITDA MARGIN IS EXPECTED TO BE BETWEEN 16.5% AND 17.5% IN FINANCIAL YEAR 2025

GERRESHEIMER AG: ADJUSTED EPS IS EXPECTED TO DECREASE IN HIGH DOUBLE-DIGIT PERCENTAGE RANGE AND MAY EVEN TURN NEGATIVE IN FY 2025

GERRESHEIMER AG: NEW INVESTIGATIONS INITIATED BY CO INDICATE THAT INDIVIDUAL EMPLOYEES VIOLATED INTERNAL GUIDELINES AND IFRS REGULATIONS

Source text: ID:nEQ5Ry8nda

Further company coverage: GXIG.DE

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Gerresheimer AG

See all news